Search Login Register

Sickle Cell Trait Summary

Description: The condition of being heterozygous for hemoglobin S.

Also Known As: Cell Trait, Sickle; Cell Traits, Sickle; Sickle Cell Traits; Trait, Sickle Cell; Traits, Sickle Cell

Networked: 457 relevant articles (13 outcomes, 42 trials/studies) for this Disease

Key Drugs and Agents for Sickle Cell Trait

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Iron : 3 outcomes 1 study in 14 results : IBA
  2. Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase) : 2 outcomes 1 study in 19 results : IBA
  3. Hemoglobins (Hemoglobin) : 1 outcome 10 studies in 84 results : IBA
  4. hemoglobin AS : 1 outcome 5 studies in 48 results : IBA
  5. Sickle Hemoglobin : 1 outcome 2 studies in 34 results : IBA
  6. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 1 outcome 1 study in 4 results : IBA
  7. Aspirin (Acetylsalicylic Acid) : 1 outcome 1 study in 1 result : FDA 80 Generic
  8. Complement Receptors (Complement Receptor) : 1 outcome in 2 results : IBA
  9. Cytokines : 1 outcome in 1 result : IBA
  10. Proteins (Proteins, Gene) : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Sickle Cell Trait

  1. Sickle Cell Anemia (Hemoglobin S Disease)
  2. Malaria
  3. Infection
  4. Glucosephosphate Dehydrogenase Deficiency
  5. Falciparum Malaria (Plasmodium falciparum Malaria)
Show All >>

Key Therapies for Sickle Cell Trait

Efficacy Chart >>
  1. Chemoprevention : 1 outcome in 2 results
  2. Mosquito Nets : 1 outcome in 1 result
  3. Transplantation (Transplant Recipients) : 1 outcome in 1 result
  4. Cardiopulmonary Bypass (Heart-Lung Bypass) : 7 results
  5. Transplants (Transplant) : 5 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.